Biotech Busine$$ Daily (BNT, TEVA, BPAX, NCST, RPRX, VRTX)
Bentley Pharmaceuticals Inc. (NYSE: BNT) will be purchased by Teva Pharmaceutical Industries (NASDAQ: TEVA) for $360 million. Bentley shareholders will receive $15 per share and an undisclosed amount of shares ...Read Full Story »

